Advances in targeting 'undruggable'transcription factors with small molecules

MJ Henley, AN Koehler - Nature Reviews Drug Discovery, 2021 - nature.com
Transcription factors (TFs) represent key biological players in diseases including cancer,
autoimmunity, diabetes and cardiovascular disease. However, outside nuclear receptors …

Melatonin and multiple sclerosis: Antioxidant, anti-inflammatory and immunomodulator mechanism of action

A Muñoz-Jurado, BM Escribano… - …, 2022 - Springer
Background Melatonin is an indole hormone secreted primarily by the pineal gland that
showing anti-oxidant, anti-inflammatory and anti-apoptotic capacity. It can play an important …

Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response

V Kostenko, O Akimov, O Gutnik, H Kostenko… - Heliyon, 2023 - cell.com
One of the adverse outcomes of acute inflammatory response is progressing to the chronic
stage or transforming into an aggressive process, which can develop rapidly and result in …

NF-κB signaling and inflammation—Drug repurposing to treat inflammatory disorders?

A Roberti, LE Chaffey, DR Greaves - Biology, 2022 - mdpi.com
Simple Summary Since its first description 35 years ago, the transcription factor NF-κB
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …

Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse …

S Sharma, S Risen, VS Gilberto, S Boland… - ACS Chemical …, 2024 - ACS Publications
Multiple sclerosis (MS) is a debilitating autoimmune disease that impacts millions of patients
worldwide, disproportionately impacting women (4: 1), and often presenting at highly …

A systematic review of Mendelian randomization studies on multiple sclerosis

T Fazia, GN Baldrighi, A Nova… - European Journal of …, 2023 - Wiley Online Library
Mendelian randomization (MR) is a powerful approach for assessing the causal effect of
putative risk factors on an outcome, using genetic variants as instrumental variables. The …

Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease

EV Mitroshina, MO Savyuk, E Ponimaskin… - Frontiers in cell and …, 2021 - frontiersin.org
Hypoxia is one of the most common pathological conditions, which can be induced by
multiple events, including ischemic injury, trauma, inflammation, tumors, etc. The body's …

Microglial NLRP3 inflammasome activation in multiple sclerosis

M Olcum, B Tastan, C Kiser, S Genc, K Genc - Advances in protein …, 2020 - Elsevier
Multiple sclerosis (MS) is a chronic, autoimmune and neuroinflammatory disease of the
central nervous system (CNS) mediated by autoreactive T cells directed against myelin …

[HTML][HTML] Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer

R Eskandani, M Kazempour, R Farahzadi… - Biomedicine & …, 2022 - Elsevier
The transcription factor nuclear factor-κB (NF-κB) is a critical regulator of the immune
response, inflammation, cell growth, and survival. Canonical and non-canonical pathways …

Neuroprotective panel of olive polyphenols: Mechanisms of action, anti-demyelination, and anti-stroke properties

T Grubić Kezele, B Ćurko-Cofek - Nutrients, 2022 - mdpi.com
Neurological diseases such as stroke and multiple sclerosis are associated with high
morbidity and mortality, long-term disability, and social and economic burden. Therefore …